posted on 2023-04-04, 01:41authored byHao Chen, Gregory M. Cresswell, Sarah Libring, Mitchell G. Ayers, Jinmin Miao, Zhong-Yin Zhang, Luis Solorio, Timothy L. Ratliff, Michael K. Wendt
Corresponding representative dot plots for the quantification in figure 2B-C and additional T cell exhaustion marker analysis in the study of D2.A1 model.
Funding
HHS | NIH | National Cancer Institute (NCI)
Indiana Clinical and Translational Science Institute
American Cancer Society (ACS)
History
ARTICLE ABSTRACT
Findings present inhibition of SHP2 as a therapeutic option to limit breast cancer metastasis by promoting antitumor immunity.